De novo variants in CELF2 that disrupt the nuclear localization signal cause developmental and epileptic encephalopathy

Toshiyuki Itai¹, Kohei Hamanaka¹, Kazunori Sasaki², Matias Wagner^{3

4}, Urania Kotzaeridou⁵, Ines Brösse⁵, Markus Ries⁵, Yu Kobayashi⁶, Jun Tohyama⁶, Mitsuhiro Kato⁷, Winnie P Ong⁸, Hui B Chew⁸, Kavitha Rethanavelu⁸, Emmanuelle Ranza⁹, Xavier Blanc⁹, Yuri Uchiyama^{1

10}, Naomi Tsuchida^{1

10}, Atsushi Fujita¹, Yoshiteru Azuma¹, Eriko Koshimizu¹, Takeshi Mizuguchi¹, Atsushi Takata¹, Noriko Miyake¹, Hidehisa Takahashi², Etsuko Miyagi¹¹, Yoshinori Tsurusaki¹², Hiroshi Doi¹³, Masataka Taguri¹⁴, Stylianos E Antonarakis^{9

15}, Mitsuko Nakashima¹⁶, Hirotomo Saitsu¹⁶, Satoko Miyatake^{1

17}, Naomichi Matsumoto¹

Affiliations

¹ Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
² Department of Molecular Biology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
³ Institute of Human Genetics, School of Medicine, Technische Universität München, Munich, Germany.
⁴ Institute of Neurogenomics, Helmholtz Zentrum München, Neuherberg, Germany.
⁵ Department of Child Neurology and Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
⁶ Department of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, Niigata, Japan.
⁷ Department of Pediatrics, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan.
⁸ Department of Genetics, Kuala Lumpur Hospital, Jalan Pahang, Kuala Lumpur, Malaysia.
⁹ Swiss Institute of Genomic Medicine, Medigenome, Geneva, Switzerland.
¹⁰ Rare Disease Genomics Department, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
¹¹ Department of Obstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
¹² Faculty of Nutritional Science, Sagami Women's University, Sagamihara, Kanagawa, Japan.
¹³ Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
¹⁴ Department of Data Science, Yokohama City University School of Data Science, Yokohama, Kanagawa, Japan.
¹⁵ Department of Genetic Medicine, University of Geneva Medical School, Geneva, Switzerland.
¹⁶ Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
¹⁷ Clinical Genetics Department, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.

PMID: 33131106
DOI: 10.1002/humu.24130

De novo variants in CELF2 that disrupt the nuclear localization signal cause developmental and epileptic encephalopathy

Toshiyuki Itai et al. Hum Mutat. 2021 Jan.

. 2021 Jan;42(1):66-76.

doi: 10.1002/humu.24130. Epub 2020 Nov 10.

Authors

Affiliations

¹ Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
² Department of Molecular Biology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
³ Institute of Human Genetics, School of Medicine, Technische Universität München, Munich, Germany.
⁴ Institute of Neurogenomics, Helmholtz Zentrum München, Neuherberg, Germany.
⁵ Department of Child Neurology and Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
⁶ Department of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, Niigata, Japan.
⁷ Department of Pediatrics, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan.
⁸ Department of Genetics, Kuala Lumpur Hospital, Jalan Pahang, Kuala Lumpur, Malaysia.
⁹ Swiss Institute of Genomic Medicine, Medigenome, Geneva, Switzerland.
¹⁰ Rare Disease Genomics Department, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
¹¹ Department of Obstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
¹² Faculty of Nutritional Science, Sagami Women's University, Sagamihara, Kanagawa, Japan.
¹³ Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
¹⁴ Department of Data Science, Yokohama City University School of Data Science, Yokohama, Kanagawa, Japan.
¹⁵ Department of Genetic Medicine, University of Geneva Medical School, Geneva, Switzerland.
¹⁶ Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
¹⁷ Clinical Genetics Department, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.

PMID: 33131106
DOI: 10.1002/humu.24130

Abstract

We report heterozygous CELF2 (NM_006561.3) variants in five unrelated individuals: Individuals 1-4 exhibited developmental and epileptic encephalopathy (DEE) and Individual 5 had intellectual disability and autistic features. CELF2 encodes a nucleocytoplasmic shuttling RNA-binding protein that has multiple roles in RNA processing and is involved in the embryonic development of the central nervous system and heart. Whole-exome sequencing identified the following CELF2 variants: two missense variants [c.1558C>T:p.(Pro520Ser) in unrelated Individuals 1 and 2, and c.1516C>G:p.(Arg506Gly) in Individual 3], one frameshift variant in Individual 4 that removed the last amino acid of CELF2 c.1562dup:p.(Tyr521Ter), possibly resulting in escape from nonsense-mediated mRNA decay (NMD), and one canonical splice site variant, c.272-1G>C in Individual 5, also probably leading to NMD. The identified variants in Individuals 1, 2, 4, and 5 were de novo, while the variant in Individual 3 was inherited from her mosaic mother. Notably, all identified variants, except for c.272-1G>C, were clustered within 20 amino acid residues of the C-terminus, which might be a nuclear localization signal. We demonstrated the extranuclear mislocalization of mutant CELF2 protein in cells transfected with mutant CELF2 complementary DNA plasmids. Our findings indicate that CELF2 variants that disrupt its nuclear localization are associated with DEE.

Keywords: CELF2; autistic features; de novo variant; developmental and epileptic encephalopathy; hypotonia.

PubMed Disclaimer

References

REFERENCES

1. Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A.S., & Sunyaev, S.R. (2010). A method and server for predicting damaging missense mutations. Nature Methods, 7(4), 248-249. https://doi.org/10.1038/nmeth0410-248
1. Aoi, H., Mizuguchi, T., Ceroni, J. R., Kim, V. E. H., Furquim, I., Honjo, R. S., Iwaki, T., Suzuki, T., Sekiguchi, F., Uchiyama, Y., Azuma, Y., Hamanaka, K., Koshimizu, E., Miyatake, S., Mitsuhashi, S., Takata, A., Miyake, N., Takeda, S., Itakura, A., … Matsumoto, N. (2019). Comprehensive genetic analysis of 57 families with clinically suspected Cornelia de Lange syndrome. Journal of Human Genetics, 64(10), 967-978. https://doi.org/10.1038/s10038-019-0643-z
1. Bernhofer, M., Goldberg, T., Wolf, S., Ahmed, M., Zaugg, J., Boden, M., & Rost, B. (2018). NLSdb-major update for database of nuclear localization signals and nuclear export signals. Nucleic Acids Research, 46(D1), D503-D508. https://doi.org/10.1093/nar/gkx1021
1. Blech-Hermoni, Y., Stillwagon, S. J., & Ladd, A. N. (2013). Diversity and conservation of CELF1 and CELF2 RNA and protein expression patterns during embryonic development. Developmental Dynamics, 242(6), 767-777. https://doi.org/10.1002/dvdy.23959
1. Choi, D. K., Ito, T., Tsukahara, F., Hirai, M., & Sakaki, Y. (1999). Developmentally-regulated expression of mNapor encoding an apoptosis-induced ELAV-type RNA binding protein. Gene, 237(1), 135-142. https://doi.org/10.1016/s0378-1119(99)00312-1

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information
Molecular Biology Databases

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

De novo variants in CELF2 that disrupt the nuclear localization signal cause developmental and epileptic encephalopathy

Affiliations

De novo variants in CELF2 that disrupt the nuclear localization signal cause developmental and epileptic encephalopathy

Authors

Affiliations

Abstract

References

REFERENCES

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases